Journal
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY
Volume 47, Issue -, Pages 14-26Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.bpobgyn.2017.08.006
Keywords
Human papillomavirus; Cancer; Attributable fraction; Papillomavirus vaccines; Prevention; Time trends
Categories
Funding
- Institute de Salud Carlos III-ISCII (Spanish Government)
- FEDER funds/European Regional Development Fund (ERDF) A WAY TO BUILD Europe [RD12/0036/0056, 016/12/00401]
- , Agencia de Gestion de Ayudas Universitarias y de Investigacion (AGAUR) de la Generalitat de Catalunya [2014SGR1077]
- Recercaixa [MD088652]
- Spanish Ministry of Economy and Competitiveness Carlos III Institute of Health (Rio Hortega) [CM15/00061]
Ask authors/readers for more resources
Human papillomavirus (HPV) infection is recognized as one of the major causes of infection-related cancer in both men and women. High-risk HPV types are not only responsible for virtually all cervical cancer cases but also for a fraction of cancers of the vulva, vagina, penis, anus, and head and neck cancers. Furthermore, HPV is also the cause of anogenital warts and recurrent respiratory papillomatosis. Despite the availability of multiple preventative strategies, HPV-related cancer remains a leading cause of morbi-mortality in many parts of the world, particularly in less developed countries. Thus, in this review, we summarize the latest estimates of the global burden of HPV-related diseases, trends, the attributable fraction by HPV types, and the potential preventative fraction. (C) 2017 Published by Elsevier Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available